CATH Classification
| Level | CATH Code | Description | 
|---|---|---|
|   | 3 | Alpha Beta | 
|   | 3.40 | 3-Layer(aba) Sandwich | 
|   | 3.40.640 | Aspartate Aminotransferase; domain 2 | 
|   | 3.40.640.10 | Type I PLP-dependent aspartate aminotransferase-like (Major domain) | 
Domain Context
CATH Clusters
| Superfamily | Type I PLP-dependent aspartate aminotransferase-like (Major domain) | 
| Functional Family | 
Enzyme Information
| 2.6.1.7 | Kynurenine--oxoglutarate transaminase. based on mapping to UniProt Q8N5Z0 L-kynurenine + 2-oxoglutarate = 4-(2-aminophenyl)-2,4-dioxobutanoate + L-glutamate. -!- Also acts on 3-hydroxykynurenine. -!- The product 4-(2-aminophenyl)-2,4-dioxobutanoate is converted into kynurenate by a spontaneous reaction. | 
| 2.6.1.39 | 2-aminoadipate transaminase. based on mapping to UniProt Q8N5Z0 L-2-aminoadipate + 2-oxoglutarate = 2-oxoadipate + L-glutamate. | 
UniProtKB Entries (1)
| Q8N5Z0 | AADAT_HUMAN Homo sapiens Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial | 
PDB Structure
| PDB | 4GE9 | 
| External Links | |
| Method | X-RAY DIFFRACTION | 
| Organism | |
| Primary Citation | Structure-Based Design of Irreversible Human KAT II Inhibitors: Discovery of New Potency-Enhancing Interactions. ACS Med Chem Lett | 
